» Articles » PMID: 36309659

Coronary Artery Calcification in Patients with Advanced Chronic Kidney Disease

Overview
Publisher Biomed Central
Date 2022 Oct 30
PMID 36309659
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Cardiovascular disease (CVD) is associated with higher morbidity and mortality rates in patients with chronic kidney disease (CKD). Studies have shown that vascular calcification is a major predictor of CVD. Vascular calcification in the CKD population is associated with various risk factors, and changes in bone and mineral metabolism have been linked to an increased risk of atherosclerosis. Therefore, we aimed to investigate the correlation between vascular calcification and bone metabolism, which is necessary to improve the survival and prognosis of patients with CKD.

Methods: We included 146 patients with CKD who received coronary artery calcification (CAC) scores at our hospital from May 2017 to November 2018. Spearman rank correlation analysis, Mann-Whitney U test, and Kaplan-Meier method were used to analyze laboratory data and all-cause mortality.

Results: In the 146 patients, chronic glomerulonephritis accounted for the most common cause of CKD, at approximately 39.0%. Spearman rank correlation analysis on the factors influencing vascular calcification in patients with CKD showed that CAC score was significantly and positively correlated with C-reactive protein, N-terminal/midregion osteocalcin (N-MID), N-terminal peptide of type 1 procollagen (P1NP), β-cross-linked C-telopeptide of type 1 collagen (β-CTx), and parathyroid hormone (P = 0.0423, P = 0.0432, P = 0.0235, P = 0.0061, P < 0.0001, respectively). Serum calcium levels were positively correlated with N-MID, P1NP, β-CTx, and iPTH (r = 0.19, r = 0.24, r = 0.21, r = 0.21, respectively), and serum phosphorus levels were positively correlated with N-MID, P1NP, β-CTx, and iPTH (r = 0.50, r = 0.37, r = 0.50, r = 0.55, respectively). However, no difference was found in CVC scores among patients with CKD in different stages and receiving different treatments. In the Kaplan-Meier analysis of all-cause hospitalization and mortality rates, patients with CAC > 400 had a higher risk.

Conclusion: We found that the primary cause of CKD is glomerulonephritis, and the CAC score is positively correlated with inflammatory and bone metabolism markers, with a higher risk of all-cause mortality and cardiovascular hospitalization when the CAC score is greater than 400.

Citing Articles

The Relationship of Fetuin-A with Coronary Calcification, Carotid Atherosclerosis, and Mortality Risk in Non-Dialysis Chronic Kidney Disease.

Mohamed O, Mohamed M, Hassan I, Alakkad A, Othman A, Setouhi A J Lipid Atheroscler. 2024; 13(2):194-211.

PMID: 38826181 PMC: 11140250. DOI: 10.12997/jla.2024.13.2.194.


Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persistent Hyperparathyroidism: A Retrospective Study.

Arabi Z, El Sarrag M, Arabi T, Alqudsi M, Shafqat A Ann Transplant. 2024; 29:e943532.

PMID: 38561931 PMC: 10998472. DOI: 10.12659/AOT.943532.


The Associations Between Abdominal Obesity and Coronary Artery Calcification in Chronic Kidney Disease Population.

Liu P, Chen J Int J Nephrol Renovasc Dis. 2024; 17:39-45.

PMID: 38317662 PMC: 10840527. DOI: 10.2147/IJNRD.S446445.


Establishment and evaluation of a nomogram prediction model for the risk of vascular calcification in stage 5 chronic kidney disease patients.

Yang Y, Liang W, Gong W, Li S, Chen S, Yang Z Sci Rep. 2024; 14(1):1025.

PMID: 38200088 PMC: 10781805. DOI: 10.1038/s41598-023-48275-2.


Pathophysiology and Clinical Impacts of Chronic Kidney Disease on Coronary Artery Calcification.

Dai Z, Zhang X J Cardiovasc Dev Dis. 2023; 10(5).

PMID: 37233174 PMC: 10218918. DOI: 10.3390/jcdd10050207.

References
1.
. Journal club. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Kidney Int. 2011; 80(12):1250-1. DOI: 10.1038/ki.2011.376. View

2.
Paloian N, Giachelli C . A current understanding of vascular calcification in CKD. Am J Physiol Renal Physiol. 2014; 307(8):F891-900. PMC: 4200295. DOI: 10.1152/ajprenal.00163.2014. View

3.
Alfieri C, Forzenigo L, Tripodi F, Meneghini M, Regalia A, Cresseri D . Long-term evaluation of coronary artery calcifications in kidney transplanted patients: a follow up of 5 years. Sci Rep. 2019; 9(1):6869. PMC: 6499881. DOI: 10.1038/s41598-019-43216-4. View

4.
Lv J, Neal B, Ehteshami P, Ninomiya T, Woodward M, Rodgers A . Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis. PLoS Med. 2012; 9(8):e1001293. PMC: 3424246. DOI: 10.1371/journal.pmed.1001293. View

5.
Kaesler N, Goettsch C, Weis D, Schurgers L, Hellmann B, Floege J . Magnesium but not nicotinamide prevents vascular calcification in experimental uraemia. Nephrol Dial Transplant. 2019; 35(1):65-73. DOI: 10.1093/ndt/gfy410. View